SCHEMBL7301032

SCHEMBL7301032

CCOC(=O)CCN(C(=O)[C@H](CC(=O)OC(C)(C)C)NS(=O)(=O)c1cccnc1)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
F10 P00742 1/20 0.35
F2 P00734 1/20 0.35
GAA P10253 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
ITGAV P06756 2/20 0.34
HIF1A Q16665 1/20 0.34
TBXAS1 P24557 2/20 0.34
TBXA2R P21731 1/20 0.34
ITGB3 P05106 5/20 0.33
ITGA2B P08514 5/20 0.33
GPR119 Q8TDV5 1/20 0.33
ADAM17 P78536 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NR1H4 Q96RI1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8717243 0.90 SLC1A3 (0.38) TSHRF10F2GAASLC1A3
SCHEMBL7303910 0.84 ACACB (0.43) F10F2GAA
SCHEMBL7298351 0.83 F2 (0.43) F10F2HSD17B10
SCHEMBL7303719 0.83 EEF2K (0.36) F10F2GPR119HSD17B10
SCHEMBL7295250 0.82 L3MBTL1 (0.39) F10GPR119HSD17B10NR1H4
SCHEMBL8947611 0.82 CA12 (0.36) F2ITGB3ITGA2BHSD17B10
SCHEMBL7304125 0.82 CA12 (0.36) F2ITGB3ITGA2BHSD17B10
SCHEMBL7296038 0.81 CYP1A2 (0.31) F10
SCHEMBL27380499 0.81 CYP1A2 (0.31) F10
SCHEMBL7298089 0.80 MMP13 (0.34) F10F2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed